Vimarsana
Biggest News Aggregation in the World

Response Prediction News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Response Prediction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Response Prediction Today - Breaking & Trending Today

Brain Scan with AI Can Predict Whether the Antidepressant Sertraline Will Work - Vimarsana News

Brain Scan with AI Can Predict Whether the Antidepressant Sertraline Will Work

A secondary analysis found a brain scan with an AI algorithm predicted within a week 1/3 of patients would respond to sertraline and 2/3 would not.

Artificial intelligence helps predict whether - Vimarsana News

Artificial intelligence helps predict whether

<p>In patients with major depression disorder it is, thanks to use of artificial intelligence, now possible to predict within a week whether an antidepressant will work. With the help of an AI algorithm,&nbsp;a brain scan and an individual&#39;s clinical information, researchers from Amsterdam UMC and Radboudumc could see up to 8 weeks faster whether or not the medication would work. The results of this study are published today in the American Journal of Psychiatry.</p>

Response Prediction in Oncology Clinical Trials, Upcoming Webinar Hosted by Xtalks - Vimarsana News

Response Prediction in Oncology Clinical Trials, Upcoming Webinar Hosted by Xtalks

Toronto, ON (PRWEB) October 12, 2022 -- The failure rate of late-stage oncology clinical trials is one of the highest across therapeutic areas, whereas many

Source: prweb.com
AbbVie to Highlight New Advances in Blood Cancer Research and Expanding Oncology Pipeline at 63rd ASH Annual Meeting - Vimarsana News

AbbVie to Highlight New Advances in Blood Cancer Research and Expanding Oncology Pipeline at 63rd ASH Annual Meeting

ABBVie will present results from nearly 30 abstracts across eight types of cancer during the upcoming American Society of Hematology Annual Meeting in Atlanta, Georgia . "We are dedicated to transforming standards of care for people living with blood cancers," said Mohamed Zaki M.D., Ph.D, vice president and global head of oncology development, AbbVie. "The data we are presenting at the ASH Annual Meeting build on ...

AbbVie to Highlight New Advances in Blood Cancer Research and Expanding Oncology Pipeline at 63rd ASH Annual Meeting - Vimarsana News

AbbVie to Highlight New Advances in Blood Cancer Research and Expanding Oncology Pipeline at 63rd ASH Annual Meeting

/PRNewswire/ -- AbbVie (NYSE: ABBV) will present results from nearly 30 abstracts across eight types of cancer during the upcoming American Society of...